SUPN

NASD Supernus Pharmaceuticals, Inc.
Oct 31, 2026 · 4:39 AM ET EOD Market Closed

$41.92 ↑ +0.00 (+0.00%) Trading Up from the previous close of $41.92, $1.80 below the day’s high of $43.72

YTD change
-15.65%
vs 20-day SMA
+1.26%
vs 200-day SMA
-11.44%

Price ranges

Previous day
$39.53 $43.72
open $42.07 close $41.92
-$0.15 (-0.36%)
Today
$39.53 $43.72
$41.92
Past week
$39.58 $44.31
from $42.07 now $41.92
-$0.15 (-0.36%)
Past month
$37.54 $44.31
from $42.18 now $41.92
-$0.26 (-0.62%)
This year
$37.54 $59.68
from $49.70 now $41.92
-$7.78 (-15.65%)

Price & Performance

-5.93 (-12.39%) / 6M

$36.73$42.30$47.86$53.43May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 31.6% away from all-time highs of $61.25
  • SUPN is down 16% since the beginning of the year
  • SUPN is down 26% over the past 12 months
  • SUPN is down 1% over the past 1 month
  • 9% of all SUPN investors are betting against SUPN

SUPN reads neutral: price sits above one of the two key moving averages, the 12-month move is -24.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.921707
Earnings momentum +49.2% Quarterly EPS growth
Quarterly change +49.2%

Valuation

P/E ratio N/A
Enterprise value $2.1B
Beta 0.62

Balance sheet & scale

IncomeN/A
Revenue$830.4M
Cash$372.1M
Debt$40.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $2.4B

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,417.54 +3.19%
JNJ Johnson & Johnson $273.20 -0.73%
ABBV AbbVie, Inc. $294.89 +1.41%
MRK Merck & Co., Inc. $149.52 +2.18%
RHHBY Roche Holding Ltd Sponsored ADR $61.27 +0.82%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.